Skip to main content
main-content

Heart failure

Latest articles

15-02-2017 | Heart failure | News | Article

Elevated hs-cTnT levels could indicate subclinical cardiac disease

Minor increases in high-sensitivity cardiac troponin T levels may represent an early biochemical signature of subclinical heart disease, researchers report.

Source:

Circulation 2017; Advance online publication

09-01-2017 | Heart failure | News | Article

Diabetes associated with adverse outcomes in patients with HFpEF

Diabetes is associated with poor prognosis among patients with heart failure and preserved ejection fraction, study results suggest.

Source:

Circulation 2017; Advance online publication

05-10-2016 | Heart failure | News | Article

Age key to transcatheter versus surgical aortic valve replacement choice

Researchers report that patients with severe aortic stenosis who have a shorter life expectancy or place a low value on the risk of long-term valve degeneration may have more to gain from transfemoral transcatheter aortic valve implantation than surgical replacement.

Source:

BMJ 2016; 354: i5130

29-09-2016 | Heart failure | News | Article

NSAIDs association with heart failure risk quantified

The increased risk of heart failure associated with non-steroidal anti-inflammatory drugs varies between drugs and according to dose, study findings show.

Source:

BMJ 2016; 354: i4857

31-08-2016 | Cardiology | News | Article

ICDs fail to reduce long-term mortality in non-ischaemic HF

Prophylactic implantable cardioverter–defibrillator use does not reduce long-term mortality in patients with symptomatic heart failure not caused by coronary artery disease, Danish research shows.

Source:

N Engl J Med 2016; Advance online publication

30-08-2016 | Cardiology | News | Article

Sacubitril–valsartan costs may be justified in NYHA class II-IV heart failure

Sacubitril–valsartan is cost-effective for the reduction of cardiovascular mortality and morbidity in patients with New York Heart Association class II to IV heart failure and reduced ejection fraction, US study findings indicate.

Source:

Ann Intern Med 2016; Advance online publication

24-08-2016 | Heart failure | News | Article

Imaging technique accurately diagnoses ATTR cardiac amyloidosis

Technetium 99m pyrophosphate planar cardiac imaging accurately differentiates transthyretin cardiac amyloidosis from other amyloid conditions and may also predict survival, US researchers report.

Source:

JAMA Cardiol 2016; Advance online publication 

12-08-2016 | Cardiology | News | Article

Racial and gender disparities common in ICD counselling

Less than a quarter of heart failure (HF) patients eligible for implantable cardioverter-defibrillator counselling actually receive it, with the rates even lower in women and ethnic minority patients, an observational analysis of the Get With The Guidelines-HF Program shows.

Source:

Circulation 2016; Advance online publication

02-08-2016 | Heart failure | News | Article

Advanced heart failure clinical stability not improved by liraglutide

The glucagon-like peptide 1 agonist liraglutide does not improve clinical stability in patients recently hospitalised with advanced heart failure and reduced left ventricular ejection fraction, US researchers report.

Source:

JAMA 2016; 316: 500–508

01-08-2016 | Heart failure | News | Article

Obesity underlies many current-era high-output HF cases

The causes of high-output heart failure have changed over time, say Mayo Clinic researchers.

Source:

J Am Coll Cardiol 2016; 68: 473–482, 483–486

29-07-2016 | Heart failure | News | Article

HF patients rarely tested for CAD

Tests for ischaemic coronary artery disease are badly underutilised in patients with new-onset heart failure, research shows.

Source:

J Am Coll Cardiol 2016; 68: 450–458, 459–460

19-07-2016 | Heart failure | News | Article

Outcomes may be good after ejection fraction recovery

Recovery from a reduced ejection fraction appears to be a predictor of good outcomes in patients with heart failure, a retrospective analysis shows.

Source:

JAMA Cardiol 2016; Advance online publication

18-07-2016 | Heart failure | News | Article

HF and ejection fraction both impact CABG outcomes

Both heart failure and reduced ejection fraction influence the outcomes of patients undergoing coronary artery bypass grafting, say researchers. 

Source:

JAMA Cardiol 2016; Advance online publication

15-07-2016 | Heart failure | News | Article

Editor's pick

Post-MI heart failure increases cancer risk

Myocardial infarction survivors who have heart failure are more likely to develop cancer than their heart failure-free counterparts, indicates research published in the Journal of the American College of Cardiology.

Source:

J Am Coll Cardiol 2016; 68: 265–271, 272–273

13-07-2016 | Heart failure | News | Article

Sacubitril plus valsartan reduces early readmission risk in HF

The risk of readmission within 30 days of heart failure hospitalisation is reduced by a quarter for patients receiving sacubitril/valsartan compared with those receiving enalapril, an analysis of PARADIGM-HF trial data shows.

Source:

J Am Coll Cardiol 2016; 68: 241–248, 249–251

12-07-2016 | Heart failure | News | Article

AHA guidance rounds up drugs requiring caution in heart failure

The American Heart Association has published a scientific statement that provides a comprehensive list of drugs, including complementary/alternative medications, that may cause or exacerbate heart failure.

Source:

Circulation 2016; Advance online publication

08-07-2016 | Heart failure | News | Article

Obesity should be tackled in HFpEF patients

Obesity is a major contributor to breathlessness in patients who have heart failure with preserved ejection fraction, say researchers.

Source:

J Am Coll Cardiol 2016; 68: 189–199, 200–203

05-07-2016 | Heart failure | News | Article

Anaemia in heart failure may impact prognosis

Anaemia is common in patients with heart failure, regardless of the underlying phenotype, and is often associated with iron deficiency, UK researchers report.

Source:

JAMA Cardiol 2016; Advance online publication

28-06-2016 | Heart failure | News | Article

MOOD-HF supports lack of antidepressant efficacy in HF patients

Escitalopram influences neither depressive symptoms nor medical outcomes when compared with placebo in patients with heart failure and depression, show the MOOD-HF findings.

Source:

JAMA 2016; 315: 2683–2693

27-06-2016 | Heart failure | News | Article

Elevated troponin I should not rule out donor hearts

Donor cardiac troponin I level is not associated with intermediate-term mortality, cardiac allograft vasculopathy or primary graft failure in patients receiving heart transplants, US researchers report.

Source:

Circ Heart Fail 2016; Advance online publication

image credits